P455 Improvement of ulcerative-colitis-associated microbiota dysbiosis after treatment with mesalazine-MMX (Mezavant®) using mucosal Faecalobacterium prausnitzii/Escherichia coli index as a marker

Autor: Miquel Cusachs, J.O., Busquets Casals, D., Serra-Pages, M., Garcia-Gil, J., Aldeguer Manté, X.
Zdroj: In Journal of Crohn's and Colitis February 2014 8 Supplement 1:S255-S256
Databáze: ScienceDirect